Alto Neuroscience has started a Phase 2b trial of ALTO-207 [...]
Cidara Therapeutics’ investigational long-acting antiviral, CD388, has achieved statistically significant [...]
Alto Neuroscience has started a Phase 2b trial of ALTO-207 [...]
Cidara Therapeutics’ investigational long-acting antiviral, CD388, has achieved statistically significant [...]